NTNG1 and ovarian carcinoma: The KM plotter indicated that a higher expression level of the NTNG1 gene was related to a shorter PFS of ovarian cancer patients in overall as well as in the subgroup that received cisplatin treatments (p = 0.005, p < 0.001) (Supplementary Figures 1, 2).